Genevieve Tonog, Hyeonjun Yu, Sung-Kwon Moon, Sanghyun Lee, Hyeleen Jeong, Hae Soung Kim, Kwang Bin Kim, Hyung Joo Suh, Hoon Kim
{"title":"枯草芽孢杆菌生物转化的大蒜刺激肠道免疫系统并调节肠道微生物群的组成","authors":"Genevieve Tonog, Hyeonjun Yu, Sung-Kwon Moon, Sanghyun Lee, Hyeleen Jeong, Hae Soung Kim, Kwang Bin Kim, Hyung Joo Suh, Hoon Kim","doi":"10.1002/mnfr.202400504","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Scope</h3>\n \n <p>This study evaluates the potential of bioconverted garlic ferments (BGFs) to stimulate the intestinal immune system and modulate cecal microbiota composition.</p>\n </section>\n \n <section>\n \n <h3> Methods and results</h3>\n \n <p>In vitro, BGF significantly enhances Peyer's patch (PP)-mediated bone marrow cell proliferation and increases the production of interferon-gamma (IFN-γ), granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin (IL)-6, and immunoglobulin A (IgA) but not IL-4, IL-5, and immunoglobulin E (IgE). Oral administration of BGF to C3H/HeN mice for 4 weeks significantly increases the GM-CSF (42.1–45.8 pg mL<sup>−1</sup>) and IFN-γ (6.5–12.1 pg mL<sup>−1</sup>) levels in PP cells. BGF also significantly elevates the levels of tumor necrosis factor-alpha (TNF-α, 165.0–236.3 pg mg<sup>−1</sup>), GM-CSF (2.4–3.0 ng mg<sup>−1</sup>), and IFN-γ (1.5–3.2 ng mg<sup>−1</sup>) in the small intestinal fluid, and TNF-α (2.2–3.1 pg mL<sup>−1</sup>) and IFN-γ (10.3–0.21.5 pg mL<sup>−1</sup>) in the mouse serum. Cecal microbial analysis reveals that BGF increases Bacteroidota and Verrucomicrobiota and decreases Actinobacteria and Bacillota at the phylum level in mice. At the genus level, BGF significantly increases the abundance of <i>Fusimonas</i> (250 mg kg<sup>−1</sup> BW<sup>−1</sup> day<sup>−1</sup>), <i>Bacteroides</i> (125 and 250 mg kg<sup>−1</sup> BW<sup>−1</sup> day<sup>−1</sup>), and <i>Akkermansia</i> (125 mg kg<sup>−1</sup> BW<sup>−1</sup> day<sup>−1</sup>) and decreases that of <i>Bifidobacterium</i> (62.5 and 250 mg kg<sup>−1</sup> BW<sup>−1</sup> day<sup>−1</sup>) and <i>Limosilactobacillus</i> (125 and 250 mg kg<sup>−1</sup> BW<sup>−1</sup> day<sup>−1</sup>).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>This study provides the first evidence of BGF's ability to modulate the intestinal immune system and gut microbiota, supporting its potential as a novel functional material to enhance gut immunity.</p>\n </section>\n </div>","PeriodicalId":212,"journal":{"name":"Molecular Nutrition & Food Research","volume":"68 20","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Garlic Bioconverted by Bacillus subtilis Stimulates the Intestinal Immune System and Modulates Gut Microbiota Composition\",\"authors\":\"Genevieve Tonog, Hyeonjun Yu, Sung-Kwon Moon, Sanghyun Lee, Hyeleen Jeong, Hae Soung Kim, Kwang Bin Kim, Hyung Joo Suh, Hoon Kim\",\"doi\":\"10.1002/mnfr.202400504\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <section>\\n \\n <h3> Scope</h3>\\n \\n <p>This study evaluates the potential of bioconverted garlic ferments (BGFs) to stimulate the intestinal immune system and modulate cecal microbiota composition.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods and results</h3>\\n \\n <p>In vitro, BGF significantly enhances Peyer's patch (PP)-mediated bone marrow cell proliferation and increases the production of interferon-gamma (IFN-γ), granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin (IL)-6, and immunoglobulin A (IgA) but not IL-4, IL-5, and immunoglobulin E (IgE). Oral administration of BGF to C3H/HeN mice for 4 weeks significantly increases the GM-CSF (42.1–45.8 pg mL<sup>−1</sup>) and IFN-γ (6.5–12.1 pg mL<sup>−1</sup>) levels in PP cells. BGF also significantly elevates the levels of tumor necrosis factor-alpha (TNF-α, 165.0–236.3 pg mg<sup>−1</sup>), GM-CSF (2.4–3.0 ng mg<sup>−1</sup>), and IFN-γ (1.5–3.2 ng mg<sup>−1</sup>) in the small intestinal fluid, and TNF-α (2.2–3.1 pg mL<sup>−1</sup>) and IFN-γ (10.3–0.21.5 pg mL<sup>−1</sup>) in the mouse serum. Cecal microbial analysis reveals that BGF increases Bacteroidota and Verrucomicrobiota and decreases Actinobacteria and Bacillota at the phylum level in mice. At the genus level, BGF significantly increases the abundance of <i>Fusimonas</i> (250 mg kg<sup>−1</sup> BW<sup>−1</sup> day<sup>−1</sup>), <i>Bacteroides</i> (125 and 250 mg kg<sup>−1</sup> BW<sup>−1</sup> day<sup>−1</sup>), and <i>Akkermansia</i> (125 mg kg<sup>−1</sup> BW<sup>−1</sup> day<sup>−1</sup>) and decreases that of <i>Bifidobacterium</i> (62.5 and 250 mg kg<sup>−1</sup> BW<sup>−1</sup> day<sup>−1</sup>) and <i>Limosilactobacillus</i> (125 and 250 mg kg<sup>−1</sup> BW<sup>−1</sup> day<sup>−1</sup>).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>This study provides the first evidence of BGF's ability to modulate the intestinal immune system and gut microbiota, supporting its potential as a novel functional material to enhance gut immunity.</p>\\n </section>\\n </div>\",\"PeriodicalId\":212,\"journal\":{\"name\":\"Molecular Nutrition & Food Research\",\"volume\":\"68 20\",\"pages\":\"\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-10-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Nutrition & Food Research\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/mnfr.202400504\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"FOOD SCIENCE & TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Nutrition & Food Research","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/mnfr.202400504","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
Garlic Bioconverted by Bacillus subtilis Stimulates the Intestinal Immune System and Modulates Gut Microbiota Composition
Scope
This study evaluates the potential of bioconverted garlic ferments (BGFs) to stimulate the intestinal immune system and modulate cecal microbiota composition.
Methods and results
In vitro, BGF significantly enhances Peyer's patch (PP)-mediated bone marrow cell proliferation and increases the production of interferon-gamma (IFN-γ), granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin (IL)-6, and immunoglobulin A (IgA) but not IL-4, IL-5, and immunoglobulin E (IgE). Oral administration of BGF to C3H/HeN mice for 4 weeks significantly increases the GM-CSF (42.1–45.8 pg mL−1) and IFN-γ (6.5–12.1 pg mL−1) levels in PP cells. BGF also significantly elevates the levels of tumor necrosis factor-alpha (TNF-α, 165.0–236.3 pg mg−1), GM-CSF (2.4–3.0 ng mg−1), and IFN-γ (1.5–3.2 ng mg−1) in the small intestinal fluid, and TNF-α (2.2–3.1 pg mL−1) and IFN-γ (10.3–0.21.5 pg mL−1) in the mouse serum. Cecal microbial analysis reveals that BGF increases Bacteroidota and Verrucomicrobiota and decreases Actinobacteria and Bacillota at the phylum level in mice. At the genus level, BGF significantly increases the abundance of Fusimonas (250 mg kg−1 BW−1 day−1), Bacteroides (125 and 250 mg kg−1 BW−1 day−1), and Akkermansia (125 mg kg−1 BW−1 day−1) and decreases that of Bifidobacterium (62.5 and 250 mg kg−1 BW−1 day−1) and Limosilactobacillus (125 and 250 mg kg−1 BW−1 day−1).
Conclusion
This study provides the first evidence of BGF's ability to modulate the intestinal immune system and gut microbiota, supporting its potential as a novel functional material to enhance gut immunity.
期刊介绍:
Molecular Nutrition & Food Research is a primary research journal devoted to health, safety and all aspects of molecular nutrition such as nutritional biochemistry, nutrigenomics and metabolomics aiming to link the information arising from related disciplines:
Bioactivity: Nutritional and medical effects of food constituents including bioavailability and kinetics.
Immunology: Understanding the interactions of food and the immune system.
Microbiology: Food spoilage, food pathogens, chemical and physical approaches of fermented foods and novel microbial processes.
Chemistry: Isolation and analysis of bioactive food ingredients while considering environmental aspects.